Research
The Lancet Infectious Diseases
New Malaria Vaccine Study Shows Promising Results in Nigeria
Dr. Chidi Eze·22 June 2026·1 min read
Authors: Eze C., Adeyemi O., Bello K.
Key findings: 78% efficacy in phase II trials across 3 Nigerian states.
Researchers at University of Ibadan report 78% efficacy in phase II trials of a novel malaria vaccine candidate.
Researchers at University of Ibadan report 78% efficacy in phase II trials of a novel malaria vaccine candidate.